ABS0859 AZACITIDINE REDUCES SYMPTOMS AND UBA1 MUTATION VARIANT ALLELE FREQUENCY IN PATIENTS WITH VEXAS SYNDROME: A RETROSPECTIVE COHORT STUDY
Ubiquitin-Activating Enzyme E1 (UBA1) as a Prognostic Biomarker and Therapeutic Target in Breast Cancer: Insights into Immune Infiltration and Functional Implications
